Adicet Bio Inc (ACET)
1.45
+0.04
(+2.84%)
USD |
NASDAQ |
May 03, 16:00
1.455
0.00 (0.00%)
After-Hours: 20:00
Adicet Bio Cash from Investing (Quarterly): -0.136M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.136M |
| September 30, 2023 | -0.906M |
| June 30, 2023 | -1.507M |
| March 31, 2023 | -1.915M |
| December 31, 2022 | -6.49M |
| September 30, 2022 | -4.811M |
| June 30, 2022 | -2.849M |
| March 31, 2022 | -2.632M |
| Date | Value |
|---|---|
| December 31, 2021 | -3.078M |
| September 30, 2021 | -7.178M |
| June 30, 2021 | -0.382M |
| March 31, 2021 | 7.842M |
| December 31, 2020 | 12.45M |
| September 30, 2020 | 74.65M |
| June 30, 2020 | 23.68M |
| March 31, 2020 | 4.445M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-7.178M
Minimum
Sep 2021
74.65M
Maximum
Sep 2020
5.698M
Average
-1.206M
Median
Cash from Investing (Quarterly) Benchmarks
| Catalyst Pharmaceuticals Inc | -38.32M |
| Codexis Inc | 1.104M |
| Annexon Inc | -2.183M |
| Taysha Gene Therapies Inc | -0.01M |
| Praxis Precision Medicines Inc | -0.05M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -23.49M |
| Cash from Financing (Quarterly) | 0.076M |
| Free Cash Flow | -98.18M |
| Free Cash Flow Per Share (Quarterly) | -0.5473 |
| Free Cash Flow Yield | -157.4% |